Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:768-774
Published online before print February 12, 2004, doi: 10.1161/01.ATV.0000121572.21122.59
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/4/768    most recent
01.ATV.0000121572.21122.59v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Post, S. M.
Right arrow Articles by Princen, H. M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Post, S. M.
Right arrow Articles by Princen, H. M. G.
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrow Gene expression
Right arrow Genetically altered mice
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:768.)
© 2004 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Cholesterol 7{alpha}-Hydroxylase Deficiency in Mice on an APOE*3-Leiden Background Impairs Very-Low-Density Lipoprotein Production

Sabine M. Post; Martine Groenendijk; Karianne Solaas; Patrick C. N. Rensen; Hans M. G. Princen

From TNO Prevention and Health (S.M.P., M.G., K.S., P.C.N.R., H.M.G.P.), Gaubius Laboratory, Leiden, The Netherlands; and the Department of General Internal Medicine (P.C.N.R.), Leiden University Medical Center, Leiden, The Netherlands.

Correspondence to Dr H. M. G. Princen, Gaubius Laboratory, TNO Prevention and Health, Department of Biomedical Research, Division of Vascular and Metabolic Diseases, PO Box 2215, 2301 CE Leiden, The Netherlands. E-mail jmg.princen{at}pg.tno.nl

Objective— Cholesterol 7{alpha}-hydroxylase (cyp7a1) catalyzes the rate-limiting step in conversion of cholesterol to bile acids. To study the relationship between bile acid biosynthesis and triglyceride metabolism, we cross-bred mice lacking cyp7a1 on a hyperlipidemic APOE*3-Leiden background.

Methods and Results— Female mice received a chow or lipogenic diet. On both diets, fecal bile acid excretion was 70% decreased concomitantly with a 2-fold increased neutral sterol output. The differences in bile acid biosynthesis did not change plasma cholesterol levels. However, plasma triglyceride levels decreased by 41% and 38% in the cyp7a1-/-. APOE*3-Leiden mice as compared with APOE*3-Leiden mice on chow and lipogenic diet, respectively. Mechanistic studies showed that very-low-density lipoprotein (VLDL)–apolipoprotein B and VLDL–triglyceride production rates were reduced in cyp7a1-/-. APOE*3-Leiden mice as compared with APOE*3-Leiden mice (-34% and -35%, respectively). Cyp7a1 deficiency also increased the hepatic cholesteryl ester and triglyceride content (2.8-fold and 2.5-fold, respectively). In addition, hepatic anti-oxidative vitamin content, which can influence VLDL-production, was lower. Hepatic mRNA analysis showed decreased expression of genes involved in lipogenesis including srebf1.

Conclusions— Cyp7a1 deficiency in APOE*3-Leiden mice decreases the VLDL particle production rate, as a consequence of a strongly reduced bile acid biosynthesis, leading to a decrease in plasma triglycerides. These data underscore the close relationship between bile acid biosynthesis and triglyceride levels.


Key Words: bile acid biosynthesis • cholesterol 7{alpha}-hydroxylase • mouse • SREBP-1 • triglycerides




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
C. C. van der Hoogt, W. de Haan, M. Westerterp, M. Hoekstra, G. M. Dallinga-Thie, J. A. Romijn, H. M. G. Princen, J. W. Jukema, L. M. Havekes, and P. C. N. Rensen
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
J. Lipid Res., August 1, 2007; 48(8): 1763 - 1771.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Post, M. Groenendijk, C. C. van der Hoogt, C. Fievet, G. Luc, M. Hoekstra, H. M.G. Princen, B. Staels, and P. C.N. Rensen
Cholesterol 7{alpha}-Hydroxylase Deficiency in Mice on an APOE*3-Leiden Background Increases Hepatic ABCA1 mRNA Expression and HDL-Cholesterol
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2724 - 2730.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Kooistra, L. Verschuren, J. de Vries-van der Weij, W. Koenig, K. Toet, H.M.G. Princen, and R. Kleemann
Fenofibrate Reduces Atherogenesis in ApoE*3Leiden Mice: Evidence for Multiple Antiatherogenic Effects Besides Lowering Plasma Cholesterol
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2322 - 2330.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. Duivenvoorden, P. J Voshol, P. C. Rensen, W. van Duyvenvoorde, J. A Romijn, J. J Emeis, L. M Havekes, and W. F Nieuwenhuizen
Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 312 - 321.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. Duivenvoorden, B. Teusink, P. C. N. Rensen, F. Kuipers, J. A. Romijn, L. M. Havekes, and P. J. Voshol
Acute inhibition of hepatic {beta}-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity
J. Lipid Res., May 1, 2005; 46(5): 988 - 993.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Zhang, R. M. Lewis, C. Wang, N. Hales, and C. D. Byrne
Maternal dietary iron restriction modulates hepatic lipid metabolism in the fetuses
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R104 - R111.
[Abstract] [Full Text] [PDF]